NCT02109172View on ClinicalTrials.gov

A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions

Chronic Obstructive Pulmonary DiseaseCOPD

Interventions

DRUG

TD-4208

DRUG

Placebo

Trial Locations (1)

28207

American Health Research, Charlotte

Sponsors

Lead Sponsor

Collaborators (1)

Theravance Biopharma

All Listed Sponsors

collaborator

Theravance Biopharma

INDUSTRY

lead

Mylan Inc.

INDUSTRY